Cogent Biosciences Appoints Cole Pinnow as Chief Commercial

WALTHAM, Mass. and BOULDER, Colo., May 23, 2024 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (NASDAQ:COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today

Related Keywords

Waltham , Minnesota , United States , Canada , Andrew Robbins , Christi Waarich , Cogent Biosciences Inc , Compensation Committee Of Cogent Board Directors , Olaf College , University Of Chicago , Master Of Business Administration , Iowa State University , Abbott Laboratories , Master Of Sciences , Pfizer , Twitter , Cogent Research Team , Linkedin , Booth School Of Management , Cole Pinnow , Chief Commercial , Gastrointestinal Stromal Tumors , Chief Executive , Managing Director , Pfizer Canada , Global Franchise Lead , Breast Cancer Business , Business Administration , Booth School , Iowa State , Listing Rule , Nasdaq Stock , Compensation Committee , Cogent Biosciences , Private Securities Litigation Reform Act , Annual Report ,